An interventional study of LiDCO rapid monitor in Cardiac Surgery, sponsored by Nationwide Children's Hospital. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2016-04-15.
Sponsored by Nationwide Children's Hospital · Not applicable, Interventional, and Diagnostic
This is a study to validate the utility and accuracy of the non-invasive device (LiDCOrapid monitor) during a period of phlebotomy and graded blood loss in patients who are having cardiac surgery.
Nationwide Children's Hospital is the lead sponsor of 231 studies on the registry; 43 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 8 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Device: LiDCO rapid monitor
Technology which provides a continuous means of monitoring various hemodynamic parameters including cardiac output and pulse pressure variability.
Difference in Pulse Pressure Variability From Baseline to Post-ANH
The difference in pulse pressure variability during a period of phlebotomy and graded blood loss, measured before phlebotomy or acute normovolemic hemodilution (ANH) and immediately after.
Time frame: 1 Day
Difference in Stroke Volume Variability From Baseline to Post ANH.
The difference in stroke volume variability during a period of phlebotomy and graded blood loss, measured before phlebotomy or acute normovolemic hemodilution (ANH) and immediately after.
Time frame: 1 Day
| Milestone | LiDCO Rapid Monitor |
|---|---|
| Started | 30 |
| Completed | 30 |
| Not completed | 0 |
The difference in pulse pressure variability during a period of phlebotomy and graded blood loss, measured before phlebotomy or acute normovolemic hemodilution (ANH) and immediately after.
| % variability | LiDCO Rapid Monitor |
|---|---|
| Difference in Pulse Pressure Variability From Baseline to Post-ANH | 7.46 ± 9.149 |
The difference in stroke volume variability during a period of phlebotomy and graded blood loss, measured before phlebotomy or acute normovolemic hemodilution (ANH) and immediately after.
| % variability | LiDCO Rapid Monitor |
|---|---|
| Difference in Stroke Volume Variability From Baseline to Post ANH. | 4.46 ± 5.368 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| LiDCO Rapid Monitor | — | 0/30 (0%) | 0/30 (0%) |
| Age, Categorical(Participants) | LiDCO Rapid Monitor |
|---|---|
| <=18 years | 16 |
| Between 18 and 65 years | 14 |
| >=65 years | 0 |
| Age, Continuous(years) | LiDCO Rapid Monitor |
|---|---|
| Mean | 21.5 ± 11.018 |
| Sex: Female, Male(Participants) | LiDCO Rapid Monitor |
|---|---|
| Female | 15 |
| Male | 15 |
| Region of Enrollment(participants) | LiDCO Rapid Monitor |
|---|---|
| United States | 30 |
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nationwide Children's Hospital